This program is designed for physicians in gastroenterology and hepatology as well as physician assistants, nurse practitioners and other advanced-practice healthcare professionals interested in the latest information on diagnostic GI and state-of-the-art treatment of these illnesses.
Following this activity, the learner will have a better understanding of the current diagnosis and management of primary sclerosing cholangitis, and the relationship between primary sclerosing cholangitis and malignancy.
After continual participation in the American Journal of Gastroenterology continuing medical education activities, the participant should be able to:
- Formulate diagnostic and treatment approaches for various liver diseases, including but not limited to hepatitis B, hepatitis C, NAFLD, cirrhosis.
- Specify a treatment plan for the various gastric and esophageal diseases, including but not limited to GERD, Barrett's esophagus, eosinophilic esophagitis, gastroparesis, IBS, chronic diarrhea.
- Apply colorectal cancer screening methods and the most current screening guidelines.
- Describe nutritional issues related to GI illness and the complications facing these GI patients.
- Evaluate new and emerging endoscopic methods in the management of GI disease.
- Implement appropriate treatment strategies for the various GI illnesses facing the pediatric patient.
- Provide resources and applicable training information to GI fellows.
Authors of articles selected for AJG CME have disclosed to readers relevant financial relationships with the manufacturer(s) of any of the products or provider(s) of any of the services discussed in their article. Disclosures will appear with the article in the section labeled “Conflict of Interest.” If the authors of the article have no relationships to disclose, “none” will be listed in this section.
Journal CME Committee/Disclosures
Kenneth R. DeVault, MD, FACG, CME Editor: Consultant: Forest Labs, Given, Takeda.John R. Saltzman, MD, FACG, Chair, ACG Educational Affairs Committee: no financial relationships to disclose.
Motaz Al-Hafnawi, MD, CME Committee: no financial relationships to disclose.
Bhaumik Brahmbhatt, MD, CME Committee: no financial relationships to disclose.
Nauzer Forbes, MD, CME Committee: Research Grant: Proctor & Gamble.
Tannaz Guivatchian, MD, CME Committee: no financial relationships to disclose.
Jacob Kurlander, MD, CME Committee: no financial relationships to disclose.
Peter Lee, MD, CME Committee: no financial relationships to disclose.
Jamak Modaresi Esfeh, MD, CME Committee: no financial relationships to disclose.
William C. Palmer, MD, CME Committee: no financial relationships to disclose.
Morgan Rosenberg, MD, CME Committee: no financial relationships to disclose.
Chaorui Tian, MD, CME Committee: no financial relationships to disclose.
Ming-Hsi Wang, MD, CME Committee: no financial relationships to disclose.
Instructions on participation and receiving credit:
There are no fees for participating in or receiving credit for this educational activity. For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within one hour; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid period. One year from the release date, tests will expire and credit will no longer be offered.
Follow these steps to earn AMA PRA Category 1 Credit™:
- Read the target audience, learning objectives, and author disclosures.
- Read the article in print or online format.
- Reflect on the article.
- Access the CME Exam for the article online (http://acgjournalcme.gi.org/) and choose the best answer to each test question.
- All questions must be answered correctly to obtain credit.
- Complete the required evaluation component of the online activity and the required fields for the creation of your CME certificate.
If you have any questions or concerns regarding this activity, please contact the ACG at (301) 263–9000 or email@example.com.